Physician profile
Mark C Reilly
NPI 1184701492
$539,993.49
in general payments reported to CMS, 2019-2025
5 companies · $216K in 2025
The $216K reported for 2025 was more than what 98% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $38K · 2021: $44K · 2022: $42K · 2023: $60K · 2024: $69K · 2025: $216K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $154K · Royalty Or License: $127K · Travel and Lodging: $49K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,500 · Food and Beverage: $4,520 · Honoraria: $3,488 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $153,967.50 |
| Royalty Or License | $127,491.89 |
| Travel and Lodging | $49,132.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,500.00 |
| Food and Beverage | $4,520.29 |
| Honoraria | $3,488.00 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $450,093.24 | 2019-2025 | Pangea, Gamma, Pro |
| Synthes Gmbh | $59,816.36 | 2019-2025 | |
| Medical Device Business Services, INC. | $23,319.98 | 2023-2025 | Na, Va-Lcp, Expert Nail |
| Synthes USA Products LLC | $6,644.36 | 2020 | |
| Depuy Synthes Sales INC. | $119.55 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.